This invention relates to a solid drug formulation comprising granulates containing a therapeutically active compound of the formula (I) 1 or a geometric isomer, a stereoisomer, a pharmaceutically acceptable salt, an ester thereof or a metabolite thereof, in combination with one or more intra-granular excipients.